© PR Newswire
26.01.2026
TRUL
LISTED
CSE
Trulieve to Open Medical Cannabis Dispensary in Fort Myers, Florida
News Preview
New Lee County location will host grand opening celebration Friday, January 30thTALLAHASSEE, Fla., Jan. 26, 2026 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Fort Myers, Florida...
Themefolio
Profiler
Peergroup
© PR Newswire
26.01.2026
AMEH
LISTED
NASDAQ
Astrana Health, Inc. Schedules 2025 Fourth Quarter and Year-End Financial Results Release and Conference Call
News Preview
ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it wil...
Themefolio
Profiler
Peergroup
© PR Newswire
26.01.2026
TRUL
LISTED
CSE
Trulieve to Open Medical Cannabis Dispensary in Fort Myers, Florida
News Preview
New Lee County location will host grand opening celebration Friday, January 30thTALLAHASSEE, Fla., Jan. 26, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Fort Myers,...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
26.01.2026
TKOMF
LISTED
OTC
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
News Preview
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a leading rare disease company, today announced the successful completion of its acquisition of Bluejay Therapeutics, a privately held biotechnology company focused on viral and liver diseases.
With the completion of the acquisition, Mirum adds worldwide rights to brelovitug, a late-stage, fully human...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© BusinessWire
26.01.2026
CON
LISTED
NASDAQ
Concentra Expands to Tucker, Georgia
News Preview
Concentra® (NYSE: CON), the nation’s leader in occupational medicine, today announced the opening of a new medical center in Tucker, Georgia. The medical center, Concentra Tucker, is conveniently located at 4434 Hugh Howell Road, Tucker, Georgia 30084.
“Georgia is a strong market for Concentra,” said Janet Cobb, MD, senior vice president of Conc...
Themefolio
Profiler
Peergroup
© BusinessWire
26.01.2026
SRPT
LISTED
NASDAQ
Sarepta Announces Positive Topline Three-Year EMBARK Results Showing ELEVIDYS Significantly Slows Disease Progression on Key Functional Measures in Ambulatory Duchenne Patients
News Preview
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced positive topline three-year functional results from Part 1-treated patients in EMBARK (Study SRP-9001-301), the global, randomized placebo-controlled Phase 3 study evaluating ELEVIDYS (delandistrogene moxeparvovec-rokl) in ambulato...
Themefolio
Profiler
Peergroup
© PR Newswire
26.01.2026
BMRN
LISTED
NASDAQ
BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility
News Preview
SAN RAFAEL, Calif., Jan. 26, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ("BioMarin") announced today that it intends to offer, subject to market and other conditions, $850 million of senior unsecured notes due 2034 (the "Notes")....
Themefolio
Profiler
Peergroup
© PR Newswire
26.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© PR Newswire
26.01.2026
PLSM
LISTED
NASDAQ
Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation
News Preview
Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month pilot; Service to be deployed via Beilinson NEXT, Beilinson's virtual hospitalRAMAT GAN, Israel, Jan. 26, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a global leader in connected home ultrasound technology, today announced...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
TRAW
LISTED
NASDAQ
Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
News Preview
Ongoing clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events, no viral rebounds to date and faster time to sustained symptom resolution; results recapitulated in PAXLOVID®-ineligible patients, representing a significant population with few effective treatment options...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
MIST
LISTED
NASDAQ
Milestone Pharmaceuticals Announces U.S. Availability of CARDAMYST™ (etripamil) Nasal Spray, the First and Only FDA-Approved Self-Administered Treatment for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
News Preview
MONTREAL and CHARLOTTE, N.C., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that CARDAMYST™ (etripamil) nasal spray, its first commercial product, is now available through U.S. retail pharmacies. CARDAMYST is a prescription medication indicated for the conversion of acute symptomatic epi...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
COGT
LISTED
NASDAQ
Cogent Biosciences Announces Breakthrough Therapy Designation for Bezuclastinib in Combination with Sunitinib for Patients with Gastrointestinal Stromal Tumors (GIST)
News Preview
- Cogent will submit the PEAK New Drug Application (NDA) under previously announced RTOR designation; on track to complete NDA submission in April 2026...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
26.01.2026
ARQT
LISTED
NASDAQ
Arcutis Biotherapeutics, Inc. Announces Termination of Promotion Agreement with Kowa
News Preview
WESTLAKE VILLAGE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that on January 23, 2026, the Company and Kowa Pharmaceuticals America, Inc. mutually agreed to terminate their p...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
LBRX
LISTED
NASDAQ
LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program
News Preview
Topline data expected in 1Q 2028...
Themefolio
Profiler
Peergroup
© Newsfile
26.01.2026
OPTI
LISTED
CSE
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
News Preview
Australia's Department of Health has issued import permits for Optimi's MDMA and psilocybin capsules for use under the Authorised Prescriber SchemeVancouver, British Columbia--(Newsfile Corp. - January 26, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of pharmace...
Themefolio
Profiler
Peergroup
© BusinessWire
26.01.2026
UTHR
LISTED
NASDAQ
United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure
News Preview
United Therapeutics Corporation (Nasdaq: UTHR) today announced positive results from its phase 1 study of miroliverELAP®, an external liver assist product, in patients with acute forms of liver failure, acute-on-chronic liver failure, and severe acute alcoholic hepatitis, collectively called acute liver failure (ALF).2
Developed by Miromatrix Me...
Themefolio
Profiler
Peergroup
© BusinessWire
26.01.2026
JANX
LISTED
NASDAQ
Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer
News Preview
Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies based on its proprietary Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms, today announced that William Go, M.D., Ph.D., has been appointe...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
ZVRA
LISTED
NASDAQ
Zevra Therapeutics to Present Multiple Analyses on MIPLYFFA® at the 22nd Annual WORLDSymposium™
News Preview
Four abstracts highlighting clinical data and real-world experience with MIPLYFFA accepted for presentation, including an oral presentation by Caroline Hastings, MD...
Themefolio
Profiler
Peergroup
© Newsfile
26.01.2026
HBFG
LISTED
CSE
Happy Belly's Yolks Breakfast Signs Franchise Agreement and Real-Estate Location in the City of Langley, British Columbia
News Preview
Toronto, Ontario--(Newsfile Corp. - January 26, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFG) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada, is pleased to announce it has signed as of Saturday, January 24th, 2026, a franchise agreement and real-estate location for Yolks Breakf...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
COLO B
LISTED
CPH
Coloplast A/S - Q1 2025/26 Earnings Release - Invitation for conference call on 6 Feb 2026 at 11.00am CET
News Preview
Friday, 6 February 2026 at 11:00-12:00am CETIn connection with the publication of Coloplast’s interim financial results for Q1 2025/26, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Col...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
PRPH
LISTED
NASDAQ
ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture
News Preview
UNIONDALE, NY, Jan. 26, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and consumer products company, today provided an operational update on the progress of its Crown Medical Collections initiative relating to legacy COVID-19 testing receivables held by its laboratory s...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
AGIO
LISTED
NASDAQ
Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET
News Preview
Agios announced the company will host a conference call and live webcast on Thursday, February 12, 2026, at 8:00 a.m. ET to report its 4Q and full year...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
LOVE
LISTED
TSX
Cannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion Strategy
News Preview
Cannara Releases Q1 FY26 Results: $30.1M revenue, 45% GM, $8.8M Adj. EBITDA, FCF $3.3M; 4.1% national share, #1 Québec; Valleyfield expansion on track....
Themefolio
Profiler
Peergroup
© BusinessWire
26.01.2026
NTRA
LISTED
NASDAQ
Prospera™ Featured in Landmark Interventional Study Advancing Lung Transplant Care
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of a new prospective clinical trial in Transplantation Direct. The study, which was conducted by The Ohio State University Wexner Medical Center (OSU-WMC), was initiated to explore whether donor-derived cell-free DNA (dd-cfDNA) sur...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
MNKD
LISTED
NASDAQ
MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy
News Preview
MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin...
Themefolio
Profiler
Peergroup
© PR Newswire
26.01.2026
2273
LISTED
HKSE
Gu Sheng Tang Donates S$1.06 Million to NTU Singapore to Advance Traditional Chinese Medicine Research and Education in Singapore
News Preview
SINGAPORE, Jan. 26, 2026 /PRNewswire/ -- Leading Traditional Chinese Medicine (TCM) healthcare group Gu Sheng Tang TCM and Nanyang Technological University, Singapore (NTU Singapore) officially launched the Gu Sheng Tang Traditional Chinese Medicine Education and Research Programme today. As part of the programme, Gu Sheng Tang TCM has donated S$1...
Themefolio
Profiler
Peergroup
© PR Newswire
26.01.2026
2269
LISTED
HKSE
WuXi Biologics and HanchorBio Enter Strategic Partnership to Advance Next-Generation Bi- and Multi-Functional Fusion Protein Pipeline
News Preview
SHANGHAI, Jan. 26, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, jointly announced today the signing...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
26.01.2026
TIVC
LISTED
NASDAQ
Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod(TM) to Commercialization at DealFlow Discovery Conference
News Preview
CEO Presentation to Include Updates and Further Information on the Following Topics:Entolimod Cell Line Verification Success;200x Manufacturing Scale-Up with Reproducible Quality;BARDA TechWatch Engagement;Creation of Velocity Bioworks, An Integrated CDMO To Accelerate Commercial Readiness FREMONT, CA / ACCESS Newswire / January 26, 2026 / Tivic He...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
45650
LISTED
XJPX
Nxera Pharma Webinar Presentation for FY2025 Financial Results
News Preview
Tokyo, Japan and Cambridge, UK, 26 January 2026 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for the year ended 31 December 2025 on Friday, 13 February 2026....
Themefolio
Profiler
Peergroup
© ACCESS Newswire
26.01.2026
REVB
LISTED
NASDAQ
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
News Preview
SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 26, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), announced today that, on January 28, 2026, the Company will implement a 1-for-4 reverse split of its common stock. The reverse stock split will be effective as of the morning of January 28, 202...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
26.01.2026
IOT
LISTED
TSX
Innovotech Inc. Presenting at the 3rd Annual DealFlow Discovery Conference
News Preview
EDMONTON, AB / ACCESS Newswire / January 26, 2026 / Innovotech Inc. (TSXV:IOT), a leading contract research organization providing proprietary antimicrobial testing and advanced laboratory services for regulated industries, today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026.Craig Milne, C...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
26.01.2026
MDCE
LISTED
OTC
Kevin O'Leary's WonderShyne Index Selects Real Game Used to Photo Match the Most Expensive Basketball Card Ever Sold
News Preview
MESA, ARIZONA / ACCESS Newswire / January 26, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that its wholly owned subsidiary, Real Game Used (RGU) (www.realgameused.com), has been commissioned by Kevin O'Leary's WonderShyne Index to conduct advanced photo-match authentication analysis on the most expensive basketball card ev...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
26.01.2026
RICHTER
LISTED
BUD
Richter Extends Its Support to Africa - The First Year of the House of Hope in Bamako in Numbers
News Preview
The First Year of the House of Hope in Bamako in Numbers BUDAPEST, HU / ACCESS Newswire / January 26, 2026 / Nearly one year has passed since the House of Hope centre, established by Richter Gedeon Plc., began providing shelter and comprehensive support to women in Bamako. During this period, almost 120 women and girls have benefited from healthcar...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
BAVA
LISTED
CPH
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
News Preview
COPENHAGEN, Denmark, January 26, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on January 7, 2026, under which the Company will repurchase shares for an amount up to DKK 150 million in the period from January 7, 2026 to February 13, 2026. The program is executed in accordance with Regulation...
Themefolio
Profiler
Peergroup
© EQS Newswire
26.01.2026
SKAN
LISTED
SIX
SKAN gibt provisorische Eckwerte zum Jahresergebnis 2025 be-kannt
News Preview
Ad hoc-Mitteilung gemäss Art. 53 KR
SKAN gibt provisorische Eckwerte zum Jahresergebnis 2025 bekannt
Allschwil, 26. Januar 2026 – Die SKAN Group AG, Weltmarktführerin für hochwertige Isolatorsysteme für aseptische Produktionsprozesse in der Pharma- und Biotech-Industrie, erwartet für das Geschäftsjahr 2025 auf Basis vorläufiger, noch nicht geprüf......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
26.01.2026
MRNA
LISTED
NASDAQ
Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026
News Preview
CAMBRIDGE, MA / ACCESS Newswire / January 26, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 13, 2026 to report its fourth quarter 2025 financial results, and provide a corporate update.A live webcast of the call will be available under "Events and Pr...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.01.2026
VANI
LISTED
NASDAQ
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
News Preview
ALAMEDA, Calif., Jan. 25, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the pricing of a best efforts registered direct offering of 1,689,200 shares of its common stock at an offering price...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
26.01.2026
XPHY
LISTED
CSE
BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion
News Preview
VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce significant progress in the development of its proprietary lead cladribine oral thin film (ODF) pro...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.01.2026
BIIB
LISTED
NASDAQ
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review
News Preview
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.01.2026
AVH
LISTED
ASX
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
News Preview
Data at 2026 Boswick Burn & Wound Symposium highlight AVITA Medical technologies RECELL, PermeaDerm, and Cohealyx in acute wound care...
Themefolio
Profiler
Peergroup
© PR Newswire
24.01.2026
CWEB
LISTED
TSX
Charlotte's Web Commends Representative Griffith for Leadership Introducing Hemp Enforcement, Modernization, and Protection (HEMP) Act
News Preview
HEMP Act Establishes FDA Oversight, Manufacturing Standards, and Consumer Safety Requirements While Preserving Legal Market for Compliant CBD ProductsLOUISVILLE, Colo., Jan. 23, 2026 /PRNewswire/ - (TSX: CWEB) (OTC: CWBHF) Charlotte's Web Holdings, Inc., the industry leader in hemp-derived wellness, today commends Representative Morgan Griffith (R...
Themefolio
Profiler
Peergroup
© PR Newswire
24.01.2026
CWEB
LISTED
TSX
Charlotte's Web Commends Representative Griffith for Leadership Introducing Hemp Enforcement, Modernization, and Protection (HEMP) Act
News Preview
HEMP Act Establishes FDA Oversight, Manufacturing Standards, and Consumer Safety Requirements While Preserving Legal Market for Compliant CBD ProductsLOUISVILLE, Colo., Jan. 23, 2026 /CNW/ - (TSX: CWEB) (OTC: CWBHF) Charlotte's Web Holdings, Inc., the industry leader in hemp-derived wellness, today commends Representative Morgan Griffith (R‑VA) fo...
Themefolio
Profiler
Peergroup
© BusinessWire
24.01.2026
ANIK
LISTED
NASDAQ
ANIK INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc.
News Preview
The law firm of Kirby McInerney LLP continues its investigation on behalf of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ:ANIK) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
IMVT
LISTED
NASDAQ
Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
News Preview
DURHAM, N.C. and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today announced that it will report its financial results for the third quarter ended December 31, 2025, and provide a business update at 8:00 a.m. ET on Friday, February 6, 2026....
Themefolio
Profiler
Peergroup
© Newsfile
23.01.2026
VIVI
LISTED
CSE
TempraMed Launches New Product "VIVI Med(TM)," Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
News Preview
Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional channelsHighlightsUses same fully patented, thermal-protection technology across product portfolio with four products in market that keep room temperature med...
Themefolio
Profiler
Peergroup
© BusinessWire
23.01.2026
SRPT
LISTED
NASDAQ
Sarepta Therapeutics to Report 3-Year Topline Data from EMBARK Study of ELEVIDYS Gene Therapy in Ambulatory Individuals with Duchenne Muscular Dystrophy
News Preview
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that on Monday, Jan. 26, 2026, at 8:30 am Eastern Time, the Company will host a webcast and conference call to present 3-year topline functional results from patients treated in Part 1 of EMBARK (Study 9001-301), the global, random...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
MRM
LISTED
NASDAQ
MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity
News Preview
TOKYO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on Nasdaq: NASDAQ: MRM, hereinafter “MEDIROM”), a company engaged in diversified healthcare businesses, has entered into a Master Service Agreement (the “MSA”) with Tools for Humanity (“TFH”) and t...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
CRVS
LISTED
NASDAQ
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M
News Preview
SOUTH SAN FRANCISCO, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced the closing of an upsized underwritten public offering of 9,085,778 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 1,185,101 a...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
RARE
LISTED
NASDAQ
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NOVATO, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 16,355 restricted stock units of the company’s common stock to nine newly hired non-executive...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ROIV
LISTED
NASDAQ
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
News Preview
BASEL, Switzerland and LONDON and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 6, 2026, to report its financial results for the second quarter ended December 31, 2026, and provide a business update....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
XTLB
LISTED
NASDAQ
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
News Preview
RAMAT GAN, ISRAEL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from The Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated January 20, 2026, notifying the Company that the Company curr...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
TELA
LISTED
NASDAQ
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
MALVERN, Pa., Jan. 23, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units c...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ERAS
LISTED
NASDAQ
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
News Preview
SAN DIEGO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it has closed its previously announced upsized public offering of 25,875,000 shar...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
OCUL
LISTED
NASDAQ
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BEDFORD, Mass., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to its newly appointed Global Chief Commercial Officer, David W. Robinson. The awards were approved by Ocu...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
SYRE
LISTED
NASDAQ
Spyre Therapeutics Announces Grants of Inducement Awards
News Preview
WALTHAM, Mass., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease and rheumatic diseases, today announced that Spyre’s independent Co...
Themefolio
Profiler
Peergroup
© Newsfile
23.01.2026
NDAT
LISTED
CSE
CSE Bulletin: Resumption - nDatalyze Corp. (NDAT)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 23 janvier/January 2026) nDatalyze Corp. ("nDatalyze" or the "Corporation”) has announced that, due to ongoing delays on the part of the Vancouver-based private company operating an international food import and distribution business (“FoodCo”) and FoodCo’s default o...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
23.01.2026
ONCO
LISTED
NEO
Onco-Innovations Announces Private Placement
News Preview
Not for distribution to United States wire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire / January 23, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") announces that it intends to complete a non-brokered private placement (the &...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
AIMI
LISTED
OTC
AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering
News Preview
OCALA, Fla., Jan. 23, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, announced today an informational update to its security ho...
Themefolio
Profiler
Peergroup
© PR Newswire
23.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Transaction in Own Shares
News Preview
For immediate release
23 January 2026
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
MARKET PURCHAS...
Themefolio
Profiler
Peergroup
© PR Newswire
23.01.2026
NDAT
LISTED
CSE
Canadian Investment Regulatory Organization Trade Resumption - NDAT
News Preview
VANCOUVER, BC, Jan. 23, 2026 /CNW/ - Trading resumes in:
Company: nDatalyze Corp.CSE Symbol: NDATAll Issues: YesResumption (ET): 12:30 PMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
